Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2025-12-29 @ 12:20 PM
Study NCT ID:
NCT05656495
Status:
COMPLETED
Last Update Posted:
2023-04-06
First Post:
2022-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19
Sponsor:
Promomed, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-15
First Submit QC Date:
None
Study First Post Date:
2022-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-04
Last Update Post Date:
2023-04-06
Last Update Post Date Type:
ACTUAL